Publication | Closed Access
HLA-Mismatched Stem-Cell Microtransplantation As Postremission Therapy for Acute Myeloid Leukemia: Long-Term Follow-Up
94
Citations
26
References
2012
Year
Microtransplantation as a postremission therapy may improve outcomes and avoid GVHD in patients with AML-CR1.
| Year | Citations | |
|---|---|---|
Page 1
Page 1